Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy (Q42969515)
Jump to navigation
Jump to search
scientific article published on August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy |
scientific article published on August 2010 |
Statements
1 reference
Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy (English)
1 reference
Chao-Hung Kuo
1 reference
Sophie S W Wang
1 reference
Wen-Hung Hsu
1 reference
Fu-Chen Kuo
1 reference
Bi-Chuang Weng
1 reference
Chia-Jung Li
1 reference
Ping-I Hsu
1 reference
Angela Chen
1 reference
Wen-Chun Hung
1 reference
Yuan-Chieh Yang
1 reference
Wen-Ming Wang
1 reference
Deng-Chyang Wu
1 reference
1 August 2010
1 reference
1 reference
1 reference
Identifiers
1 reference